These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6095626)

  • 1. [Failure to activate Epstein-Barr virus genome in a latently-infected human lymphoblastoid cell line with urine containing a bladder carcinogenesis promoter].
    Fujita J; Yoshida O
    Hinyokika Kiyo; 1984 Jul; 30(7):897-901. PubMed ID: 6095626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
    Nilsson T; Sjöblom A; Masucci MG; Rymo L
    Virology; 1993 Apr; 193(2):774-85. PubMed ID: 8384755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary bladder carcinogenesis with N-substituted aryl compounds: initiation and promotion.
    Cohen SM
    Natl Cancer Inst Monogr; 1981 Dec; (58):63-7. PubMed ID: 7341985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of results of agglutination assays with concanavalin A and carcinogenesis experiments on promoters of bladder cancer.
    Kakizoe T; Nishio Y; Ohtani M; Niijima T; Sato S; Sugimura T
    Jpn J Cancer Res; 1985 Oct; 76(10):930-6. PubMed ID: 3935624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased agglutinability of bladder cells by concanavalin A after administration of carcinogens.
    Kakizoe T; Komatsu H; Niijima T; Kawachi T; Sugimura T
    Cancer Res; 1980 Jun; 40(6):2006-9. PubMed ID: 7371036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus and tumor promoters.
    Eliasson L; Nilsson MT; Kallin B; Klein G
    Princess Takamatsu Symp; 1983; 14():139-45. PubMed ID: 6097578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugs, food additives and natural products as promoters in rat urinary bladder carcinogenesis.
    Ito N; Fukushima S; Shirai T; Hagiwara A; Imaida K
    IARC Sci Publ; 1984; (56):399-407. PubMed ID: 6536604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promotion in urinary bladder carcinogenesis.
    Cohen SM
    Environ Health Perspect; 1983 Apr; 50():51-9. PubMed ID: 6873031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus-enhancing plant promoters in east Africa.
    Mizuno F; Osato T; Imai S; Koizumi S; Aya T; Kinoshita T; Hirai N; Hirota M; Ohigashi H; Koshimizu K
    AIDS Res; 1986 Dec; 2 Suppl 1():S151-5. PubMed ID: 3030344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A short-term in vitro assay for promoter substances using human lymphoblastoid cells latently infected with Epstein-Barr virus.
    Ito Y; Yanase S; Fujita J; Harayama T; Takashima M; Imanaka H
    Cancer Lett; 1981 Jun; 13(1):29-37. PubMed ID: 6272961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
    Callahan J; Pai S; Cotter M; Robertson ES
    Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis.
    Ota T; Asamoto M; Toriyama-Baba H; Yamamoto F; Matsuoka Y; Ochiya T; Sekiya T; Terada M; Akaza H; Tsuda H
    Carcinogenesis; 2000 Jul; 21(7):1391-6. PubMed ID: 10874018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
    Lee CC; Yamamoto S; Wanibuchi H; Wada S; Sugimura K; Kishimoto T; Fukushima S
    Cancer Res; 1997 Nov; 57(21):4765-76. PubMed ID: 9354438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies.
    Chang Y; Sheen TS; Lu J; Huang YT; Chen JY; Yang CS; Tsai CH
    Lab Invest; 1998 Jun; 78(6):715-26. PubMed ID: 9645762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH; Wolf H; Minarovits J
    Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin.
    Hsu CH; Hergenhahn M; Chuang SE; Yeh PY; Wu TC; Gao M; Cheng AL
    Anticancer Res; 2002; 22(6C):4065-71. PubMed ID: 12553034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of lytic Epstein-Barr virus (EBV) infection by radiation and sodium butyrate in vitro and in vivo: a potential method for treating EBV-positive malignancies.
    Westphal EM; Blackstock W; Feng W; Israel B; Kenney SC
    Cancer Res; 2000 Oct; 60(20):5781-8. PubMed ID: 11059774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
    Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
    J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High susceptibility of p53(+/-) knockout mice in N-butyl-N-(4-hydroxybutyl)nitrosamine urinary bladder carcinogenesis and lack of frequent mutation in residual allele.
    Ozaki K; Sukata T; Yamamoto S; Uwagawa S; Seki T; Kawasaki H; Yoshitake A; Wanibuchi H; Koide A; Mori Y; Fukushima S
    Cancer Res; 1998 Sep; 58(17):3806-11. PubMed ID: 9731488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoting effects of sodium L-ascorbate on two-stage urinary bladder carcinogenesis in rats.
    Fukushima S; Imaida K; Sakata T; Okamura T; Shibata M; Ito N
    Cancer Res; 1983 Sep; 43(9):4454-7. PubMed ID: 6871876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.